SCHEMBL6839573

SCHEMBL6839573

c1ccc(-c2ncn(CCCC3CCNCC3)c2-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.52
MAPK9 P45984 2/20 0.52
CSNK1A1 P48729 2/20 0.52
CSNK1D P48730 2/20 0.52
MAP4K5 Q9Y4K4 2/20 0.52
PRKD3 O94806 1/20 0.52
FRK P42685 1/20 0.52
GSK3B P49841 1/20 0.52
PRKD2 Q9BZL6 1/20 0.52
PTGS2 P35354 4/20 0.46
MAPK13 O15264 7/20 0.43
MAPK12 P53778 7/20 0.43
MAPK11 Q15759 7/20 0.43
MAPK14 Q16539 7/20 0.43
MERTK Q12866 1/20 0.43
KDM1A O60341 1/20 0.43
AVPR2 P30518 2/20 0.41
AVPR1A P37288 2/20 0.41
EP300 Q09472 1/20 0.41
NPY1R P25929 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6843774 0.93 MAP4K4 (0.50) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL7541357 0.78 LMNA (0.64) NPY1R
SCHEMBL10441604 0.74 MAP4K4 (0.63) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL6844336 0.74 MAPK14 (0.64) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL14288452 0.74 MAP4K4 (0.86) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL8544971 0.73 ACHE (0.51)
SCHEMBL8656772 0.73 MAP4K4 (0.62) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL5093475 0.73 MAP4K4 (0.62) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL10801666 0.73 PRKD3 (0.62) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5
SCHEMBL10441819 0.72 PRKD3 (0.60) MAP4K4MAPK9CSNK1A1CSNK1DMAP4K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US claimed
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents TRPV1, TRPA1, TRPV3 MAP4K4 3127/4885MAPK9 3909/4885CSNK1A1 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.